Leidos (LDOS) -2.6%, Parsons (PSN) -4.3%, and General Dynamics (GD) -0.5% in Friday's trading as William Blair downgrades all ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Fidelity National Information Services (NYSE:FIS – Get Free Report)‘s stock had its “outperform” rating reissued by research ...
William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...
William Blair lifted their Q1 2025 earnings estimates for Watsco in a research report issued on Tuesday, February 18th. William Blair analyst R. Merkel now anticipates that the construction company ...
Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...
Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...